Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Ariosa Diagnostics Inc. Stories

2013-05-20 23:17:55

New Innovations to the Harmony Prenatal Test Now Allow for X,Y Analysis and Twin Pregnancies. San Jose, Calif. (PRWEB) May 20, 2013 Ariosa Diagnostics, maker of the non-invasive Harmony Prenatal Test for risk assessment of Down syndrome and other chromosome conditions, has announced today the expanded indication for testing of twin pregnancies naturally conceived or conceived using the patient´s own egg. In addition, Ariosa will be offering fetal X,Y analysis as an option to those...

2013-04-06 08:20:15

SAN JOSE, CA, April 6, 2013 /PRNewswire/ - The American College of Medical Genetics (ACMG) issued a position statement to support the use of non-invasive prenatal screening (NIPS) in women with singleton pregnancies. The statement can be found at this link: http://www.acmg.net/docs/nips-GiM_galley_text_130301.pdf (Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO) The statement clearly emphasizes NIPS as a screening, and not diagnostic, test. It goes on to highlight the...

2013-03-18 08:31:33

SAN JOSE, Calif., March 18, 2013 /PRNewswire/ -- Ariosa Diagnostics, maker of the non-invasive Harmony(TM) Prenatal Test for risk assessment of common genetic conditions, has announced the expansion of the Harmony Prenatal Test to include the option of Y-chromosome analysis, which can provide information on fetal sex and aneuploidy as early as 10 weeks gestation. (Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO) The new "Harmony with Y test" will offer patients and their...

2013-02-25 08:31:09

SAN JOSE, Calif., Feb. 25, 2013 /PRNewswire/ -- Ariosa Diagnostics, maker of the non-invasive Harmony(TM) Prenatal Test for detection of common genetic conditions, has announced the election of Michael A. Aicher to its Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO) Mr. Aicher has had a very successful career in the molecular diagnostics industry having spent the last 20 years in leadership positions at National Genetics Institute (NGI), a...

2013-01-09 08:26:33

SAN JOSE, Calif., Jan. 9, 2013 /PRNewswire/ -- Ariosa Diagnostics is pleased to announce that they have entered into a mutual partnership with The Doctors Laboratory, in London, to promote and distribute the Harmony Prenatal Test. Under the terms of the agreement, TDL will offer the Harmony test through their reference laboratory services to doctors and their pregnant patients. (Logo: http://photos.prnewswire.com/prnh/20121203/NE22396LOGO ) (Logo:...

2013-01-09 08:26:32

SAN JOSE, Calif., Jan. 9, 2013 /PRNewswire/ -- Ariosa Diagnostics, provider of the Harmony(TM) Prenatal Test, today announced plans to expand the indications for the Harmony test and broaden access into new, significant global markets. (Logo: http://photos.prnewswire.com/prnh/20121203/NE22396LOGO ) The Harmony test analyzes cell-free DNA circulating in maternal blood, which allows a high level of accuracy for detecting fetal trisomies, such as trisomy 21 that causes Down syndrome....

2012-12-20 08:27:42

SAN JOSE, Calif., Dec. 20, 2012 /PRNewswire/ -- Ariosa Diagnostics, provider of the Harmony(TM) Prenatal Test, today announced that WellPoint, which provides health benefits to more than 33 million people in the United States, has issued a medical policy update that deems cell-free fetal DNA-based prenatal screening for fetal aneuploidy (trisomies 13, 18, and 21) as medically necessary when certain clinical criteria are met. WellPoint supports cell-free DNA testing in women pregnant with a...

2012-12-19 08:25:13

SAN JOSE, Calif., Dec. 19, 2012 /PRNewswire/ -- Ariosa Diagnostics, maker of the Harmony Prenatal Test, today announced that it will present at the 31(st) Annual JP Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, Jan 9. (Logo: http://photos.prnewswire.com/prnh/20121203/NE22396LOGO ) Dr. Ken Song, CEO of Ariosa Diagnostics, will provide an update on the company and its product portfolio at 3:00 p.m. in the Elizabethan CD 120 Room....

2012-11-05 08:31:41

SAN JOSE, Calif., Nov. 5, 2012 /PRNewswire/ -- Ariosa Diagnostics today announced that it will present data from two recent studies on non-invasive prenatal testing (NIPT) at the American Society of Human Genetics (ASHG) Annual Meeting at The Moscone Center in San Francisco, Calif. from Nov. 6 - 11, 2012. The studies highlight a directed cell-free (cfDNA) analysis method of NIPT. (Logo: http://photos.prnewswire.com/prnh/20121105/NE05794LOGO) A poster titled "Non-invasive Chromosomal...

2012-10-25 11:26:06

REDWOOD CITY, Calif., Oct. 25, 2012 /PRNewswire/ --Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that it has commenced an action against Ariosa Diagnostics, Inc. (Ariosa) and Laboratory Corporation of America Holdings (LabCorp) in federal court in the Northern District of California. The action asserts that Ariosa and LabCorp infringe U. S. Patent No. 8,296,076 (the '076 patent) entitled "Noninvasive Diagnosis of Fetal...